JP2010530847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530847A5 JP2010530847A5 JP2010511290A JP2010511290A JP2010530847A5 JP 2010530847 A5 JP2010530847 A5 JP 2010530847A5 JP 2010511290 A JP2010511290 A JP 2010511290A JP 2010511290 A JP2010511290 A JP 2010511290A JP 2010530847 A5 JP2010530847 A5 JP 2010530847A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxylic acid
- methyl
- indan
- benzoylamino
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000001257 hydrogen Substances 0.000 claims 20
- 229910052736 halogen Inorganic materials 0.000 claims 18
- 150000002367 halogens Chemical class 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 12
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 9
- -1 ( C 1 -C 10) - alkyl carbonyl - Chemical class 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 5
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 230000004962 physiological condition Effects 0.000 claims 4
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 3
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004452 carbocyclyl group Chemical group 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004434 sulfur atom Chemical group 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000006717 (C3-C10) cycloalkenyl group Chemical group 0.000 claims 2
- MSOVLVYBZYSIEE-UHFFFAOYSA-N 5-fluoro-2-[[3-methyl-2-(2-methylpropyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=CC=C2C1 MSOVLVYBZYSIEE-UHFFFAOYSA-N 0.000 claims 2
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 1
- CGVUCVLXGMIVEB-UHFFFAOYSA-N 1,3-dimethyl-5-(5,6,7,8-tetrahydronaphthalene-1-carbonylamino)-4,6-dihydrocyclopenta[c]thiophene-5-carboxylic acid Chemical compound C1CCCC2=C1C=CC=C2C(=O)NC1(C(O)=O)CC2=C(C)SC(C)=C2C1 CGVUCVLXGMIVEB-UHFFFAOYSA-N 0.000 claims 1
- QFAHOVXWUGTKOF-UHFFFAOYSA-N 1,3-dimethyl-5-[(3-methyl-2-propan-2-yloxybenzoyl)amino]-4,6-dihydrocyclopenta[c]thiophene-5-carboxylic acid Chemical compound CC(C)OC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=C(C)SC(C)=C2C1 QFAHOVXWUGTKOF-UHFFFAOYSA-N 0.000 claims 1
- GCFWKDAGJGTYAJ-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydronaphthalen-1-ylcarbamoyl)-1,3-dihydroindene-2-carboxylic acid Chemical compound C1CCCC2=C1C=CC=C2NC(=O)C1(C(=O)O)CC2=CC=CC=C2C1 GCFWKDAGJGTYAJ-UHFFFAOYSA-N 0.000 claims 1
- YAJDKGWZDVHDQJ-UHFFFAOYSA-N 2-(5,6,7,8-tetrahydronaphthalene-1-carbonylamino)-1,3-dihydroindene-2-carboxylic acid Chemical compound C1CCCC2=C1C=CC=C2C(=O)NC1(C(=O)O)CC2=CC=CC=C2C1 YAJDKGWZDVHDQJ-UHFFFAOYSA-N 0.000 claims 1
- CZNADOCLOBYGRP-UHFFFAOYSA-N 2-[(2,3-dimethylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1C CZNADOCLOBYGRP-UHFFFAOYSA-N 0.000 claims 1
- VEICCNMVJHBRAF-UHFFFAOYSA-N 2-[(2-butan-2-yloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCC(C)OC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 VEICCNMVJHBRAF-UHFFFAOYSA-N 0.000 claims 1
- PSJYLQUBGXKMQM-UHFFFAOYSA-N 2-[(2-chloro-6-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(Cl)=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 PSJYLQUBGXKMQM-UHFFFAOYSA-N 0.000 claims 1
- OGIZPFDDOBNJOF-UHFFFAOYSA-N 2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1OC1CCC1 OGIZPFDDOBNJOF-UHFFFAOYSA-N 0.000 claims 1
- SOUFZMAJMOXZDL-UHFFFAOYSA-N 2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-4-fluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=C(F)C=CC=C3C2)C(O)=O)=C1OC1CCC1 SOUFZMAJMOXZDL-UHFFFAOYSA-N 0.000 claims 1
- VTTYTIRVPPJERI-UHFFFAOYSA-N 2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-5,6-difluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC(F)=C(F)C=C3C2)C(O)=O)=C1OC1CCC1 VTTYTIRVPPJERI-UHFFFAOYSA-N 0.000 claims 1
- JXBIPVFXGOBYMB-UHFFFAOYSA-N 2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-n-(trifluoromethylsulfonyl)-1,3-dihydroindene-2-carboxamide Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(=O)NS(=O)(=O)C(F)(F)F)=C1OC1CCC1 JXBIPVFXGOBYMB-UHFFFAOYSA-N 0.000 claims 1
- NIIGEKNBVCDNHH-UHFFFAOYSA-N 2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-n-methylsulfonyl-1,3-dihydroindene-2-carboxamide Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(=O)NS(C)(=O)=O)=C1OC1CCC1 NIIGEKNBVCDNHH-UHFFFAOYSA-N 0.000 claims 1
- DOPQJZLIDGRTTR-UHFFFAOYSA-N 2-[(2-cyclopentyl-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1C1CCCC1 DOPQJZLIDGRTTR-UHFFFAOYSA-N 0.000 claims 1
- HYDZAARUIWGUGM-UHFFFAOYSA-N 2-[(2-hex-3-en-3-yl-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCC=C(CC)C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 HYDZAARUIWGUGM-UHFFFAOYSA-N 0.000 claims 1
- RXQPOEOJKHCXBJ-UHFFFAOYSA-N 2-[(2-hexan-3-yl-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCCC(CC)C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 RXQPOEOJKHCXBJ-UHFFFAOYSA-N 0.000 claims 1
- MOZHMAHPPVDMSW-UHFFFAOYSA-N 2-[(2-phenylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C1C2=CC=CC=C2CC1(C(=O)O)NC(=O)C1=CC=CC=C1C1=CC=CC=C1 MOZHMAHPPVDMSW-UHFFFAOYSA-N 0.000 claims 1
- AXWYMDVKFCTCSX-UHFFFAOYSA-N 2-[(2-propan-2-ylsulfanylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)SC1=CC=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 AXWYMDVKFCTCSX-UHFFFAOYSA-N 0.000 claims 1
- KXMYCMOTDIYDMS-UHFFFAOYSA-N 2-[(3,5-dichloro-2-cyclobutyloxybenzoyl)amino]-5-fluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound C1C2=CC=C(F)C=C2CC1(C(=O)O)NC(=O)C1=CC(Cl)=CC(Cl)=C1OC1CCC1 KXMYCMOTDIYDMS-UHFFFAOYSA-N 0.000 claims 1
- YIJFSXUJEOMRLN-UHFFFAOYSA-N 2-[(3,5-dichloro-2-prop-2-enoxyphenyl)sulfonylamino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C1C2=CC=CC=C2CC1(C(=O)O)NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1OCC=C YIJFSXUJEOMRLN-UHFFFAOYSA-N 0.000 claims 1
- UDQBYOINRNOXIK-UHFFFAOYSA-N 2-[(3,5-dichloro-2-propan-2-yloxyphenyl)sulfonylamino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)OC1=C(Cl)C=C(Cl)C=C1S(=O)(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 UDQBYOINRNOXIK-UHFFFAOYSA-N 0.000 claims 1
- SIDVYXCWNASQAI-UHFFFAOYSA-N 2-[(3-bromo-2-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=C(Br)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 SIDVYXCWNASQAI-UHFFFAOYSA-N 0.000 claims 1
- KBANFOAVVPTUAL-UHFFFAOYSA-N 2-[(3-chloro-2-prop-2-enoxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C1C2=CC=CC=C2CC1(C(=O)O)NC(=O)C1=CC=CC(Cl)=C1OCC=C KBANFOAVVPTUAL-UHFFFAOYSA-N 0.000 claims 1
- VXGZSCGHSSMMRH-UHFFFAOYSA-N 2-[(3-chloro-2-propan-2-yloxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)OC1=C(Cl)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 VXGZSCGHSSMMRH-UHFFFAOYSA-N 0.000 claims 1
- ZHZVTFBAVDBLOC-UHFFFAOYSA-N 2-[(3-cyano-2-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=C(C#N)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 ZHZVTFBAVDBLOC-UHFFFAOYSA-N 0.000 claims 1
- XTSVCKSIAZUPIW-UHFFFAOYSA-N 2-[(3-methyl-2-pentylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCCCCC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 XTSVCKSIAZUPIW-UHFFFAOYSA-N 0.000 claims 1
- YTFNGIWSLSXQTE-UHFFFAOYSA-N 2-[(3-methyl-2-prop-1-enylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 YTFNGIWSLSXQTE-UHFFFAOYSA-N 0.000 claims 1
- BGHPCLFHLVTPQG-UHFFFAOYSA-N 2-[(3-methyl-2-prop-2-enoxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1OCC=C BGHPCLFHLVTPQG-UHFFFAOYSA-N 0.000 claims 1
- FDPUDIAMESRREB-UHFFFAOYSA-N 2-[(3-methyl-2-propan-2-yloxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)OC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 FDPUDIAMESRREB-UHFFFAOYSA-N 0.000 claims 1
- PMGMYYQMBLQSCM-UHFFFAOYSA-N 2-[(3-methyl-2-propan-2-yloxybenzoyl)amino]-5-(trifluoromethyl)-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)OC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(C(F)(F)F)=CC=C2C1 PMGMYYQMBLQSCM-UHFFFAOYSA-N 0.000 claims 1
- PFESIXUWYFDMJH-UHFFFAOYSA-N 2-[(3-methyl-2-propylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCCC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 PFESIXUWYFDMJH-UHFFFAOYSA-N 0.000 claims 1
- YDGJSBIBYHQXFD-UHFFFAOYSA-N 2-[(5-bromo-2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC(Br)=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1OC1CCC1 YDGJSBIBYHQXFD-UHFFFAOYSA-N 0.000 claims 1
- DMZUYHOTMLQCOU-UHFFFAOYSA-N 2-[(5-chloro-2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC(Cl)=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1OC1CCC1 DMZUYHOTMLQCOU-UHFFFAOYSA-N 0.000 claims 1
- ALMZBDOLVFFLJZ-UHFFFAOYSA-N 2-[(5-chloro-2-cyclobutyloxy-3-methylbenzoyl)amino]-5-fluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC(Cl)=CC(C(=O)NC2(CC3=CC(F)=CC=C3C2)C(O)=O)=C1OC1CCC1 ALMZBDOLVFFLJZ-UHFFFAOYSA-N 0.000 claims 1
- FVCATFOILDZAGK-UHFFFAOYSA-N 2-[2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC(O)=O)CC3=CC=CC=C3C2)=C1OC1CCC1 FVCATFOILDZAGK-UHFFFAOYSA-N 0.000 claims 1
- MCKNHMQFPZQZNR-UHFFFAOYSA-N 2-[[2-(2-cyclopropylethenyl)-3-methylbenzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1C=CC1CC1 MCKNHMQFPZQZNR-UHFFFAOYSA-N 0.000 claims 1
- LIZLWUTUDPLXHS-UHFFFAOYSA-N 2-[[2-(2-cyclopropylethyl)-3-methylbenzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1CCC1CC1 LIZLWUTUDPLXHS-UHFFFAOYSA-N 0.000 claims 1
- YYQWWUQBLCCMJM-UHFFFAOYSA-N 2-[[2-(2-methylbutan-2-yl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCC(C)(C)C1=CC=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 YYQWWUQBLCCMJM-UHFFFAOYSA-N 0.000 claims 1
- QQQZWHUERYOCHQ-UHFFFAOYSA-N 2-[[2-(cyclohexen-1-yl)-3-methylbenzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1C1=CCCCC1 QQQZWHUERYOCHQ-UHFFFAOYSA-N 0.000 claims 1
- JMXZJWLQQXRYCF-UHFFFAOYSA-N 2-[[2-(cyclopenten-1-yl)-3-methylbenzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1C1=CCCC1 JMXZJWLQQXRYCF-UHFFFAOYSA-N 0.000 claims 1
- SSCNSRFCMRTGIA-UHFFFAOYSA-N 2-[[2-(cyclopenten-1-yl)-3-methylbenzoyl]amino]-5-fluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC(F)=CC=C3C2)C(O)=O)=C1C1=CCCC1 SSCNSRFCMRTGIA-UHFFFAOYSA-N 0.000 claims 1
- HCKMCGDTQYQUSD-UHFFFAOYSA-N 2-[[2-(cyclopenten-1-yl)-3-methylbenzoyl]amino]-n-(trifluoromethylsulfonyl)-1,3-dihydroindene-2-carboxamide Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(=O)NS(=O)(=O)C(F)(F)F)=C1C1=CCCC1 HCKMCGDTQYQUSD-UHFFFAOYSA-N 0.000 claims 1
- LQYWUXJBHFXOOE-UHFFFAOYSA-N 2-[[2-(cyclopropylmethoxy)-3-methylbenzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC=CC=C3C2)C(O)=O)=C1OCC1CC1 LQYWUXJBHFXOOE-UHFFFAOYSA-N 0.000 claims 1
- ZAFOXUZNHBJXET-UHFFFAOYSA-N 2-[[2-[ethyl(methyl)amino]pyridine-3-carbonyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCN(C)C1=NC=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 ZAFOXUZNHBJXET-UHFFFAOYSA-N 0.000 claims 1
- BGXUVTNSAMGSBX-UHFFFAOYSA-N 2-[[2-[methyl(propan-2-yl)amino]pyridine-3-carbonyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)N(C)C1=NC=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 BGXUVTNSAMGSBX-UHFFFAOYSA-N 0.000 claims 1
- FQSVUDYSMORLMZ-UHFFFAOYSA-N 2-[[3-methyl-2-(2-methylprop-1-enyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 FQSVUDYSMORLMZ-UHFFFAOYSA-N 0.000 claims 1
- RDEPYTOUBFCJKH-UHFFFAOYSA-N 2-[[3-methyl-2-(2-methylpropanoyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)C(=O)C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 RDEPYTOUBFCJKH-UHFFFAOYSA-N 0.000 claims 1
- CVZZXXPJPJIHNE-UHFFFAOYSA-N 2-[[3-methyl-2-(2-methylpropyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 CVZZXXPJPJIHNE-UHFFFAOYSA-N 0.000 claims 1
- MXEZMFDQDAPMOI-LFYBBSHMSA-N 2-[[3-methyl-2-[(e)-pent-1-enyl]benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCC\C=C\C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 MXEZMFDQDAPMOI-LFYBBSHMSA-N 0.000 claims 1
- MXEZMFDQDAPMOI-XGICHPGQSA-N 2-[[3-methyl-2-[(z)-pent-1-enyl]benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCC\C=C/C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 MXEZMFDQDAPMOI-XGICHPGQSA-N 0.000 claims 1
- VGAHKLJXSCXITG-UHFFFAOYSA-N 2-[[5-chloro-2-[methyl(propan-2-yl)amino]pyridine-3-carbonyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)N(C)C1=NC=C(Cl)C=C1C(=O)NC1(C(O)=O)CC2=CC=CC=C2C1 VGAHKLJXSCXITG-UHFFFAOYSA-N 0.000 claims 1
- OQBZNYNXTIFJRU-UHFFFAOYSA-N 2-cyclobutyloxy-3-methyl-n-[2-(2h-tetrazol-5-yl)-1,3-dihydroinden-2-yl]benzamide Chemical compound C1CCC1OC=1C(C)=CC=CC=1C(=O)NC1(CC2=CC=CC=C2C1)C1=NN=NN1 OQBZNYNXTIFJRU-UHFFFAOYSA-N 0.000 claims 1
- IJBOCWVIWAISBD-UHFFFAOYSA-N 4,5-dichloro-2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=C(Cl)C(Cl)=CC=C3C2)C(O)=O)=C1OC1CCC1 IJBOCWVIWAISBD-UHFFFAOYSA-N 0.000 claims 1
- BMBSLTRHUKLFAS-UHFFFAOYSA-N 4,5-difluoro-2-[[3-methyl-2-(2-methylprop-1-enyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=C(F)C(F)=CC=C2C1 BMBSLTRHUKLFAS-UHFFFAOYSA-N 0.000 claims 1
- FSIHSVMSLLMCQD-UHFFFAOYSA-N 4,7-difluoro-2-[[3-methyl-2-(2-methylpropyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC(C(F)=CC=C2F)=C2C1 FSIHSVMSLLMCQD-UHFFFAOYSA-N 0.000 claims 1
- UHRGPFIPUHZRNO-UHFFFAOYSA-N 5,6-difluoro-2-[(3-methyl-2-prop-1-enylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=C(F)C=C2C1 UHRGPFIPUHZRNO-UHFFFAOYSA-N 0.000 claims 1
- HCLWVZVGWADYDV-UHFFFAOYSA-N 5,6-difluoro-2-[(3-methyl-2-propylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CCCC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=C(F)C=C2C1 HCLWVZVGWADYDV-UHFFFAOYSA-N 0.000 claims 1
- ZBYASHDLGZULQD-UHFFFAOYSA-N 5,6-difluoro-2-[[3-methyl-2-(2-methylprop-1-enyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=C(F)C=C2C1 ZBYASHDLGZULQD-UHFFFAOYSA-N 0.000 claims 1
- ZHYHJVGTMITYTB-UHFFFAOYSA-N 5-bromo-2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid;2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-5-fluoro-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC(F)=CC=C3C2)C(O)=O)=C1OC1CCC1.CC1=CC=CC(C(=O)NC2(CC3=CC(Br)=CC=C3C2)C(O)=O)=C1OC1CCC1 ZHYHJVGTMITYTB-UHFFFAOYSA-N 0.000 claims 1
- BSNIHAUVELATMP-HWKANZROSA-N 5-bromo-2-[[3-methyl-2-[(e)-prop-1-enyl]benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C\C=C\C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(Br)=CC=C2C1 BSNIHAUVELATMP-HWKANZROSA-N 0.000 claims 1
- RREJNSHSDBPJIE-UHFFFAOYSA-N 5-chloro-2-[(2-cyclobutyloxy-3-methylbenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC1=CC=CC(C(=O)NC2(CC3=CC(Cl)=CC=C3C2)C(O)=O)=C1OC1CCC1 RREJNSHSDBPJIE-UHFFFAOYSA-N 0.000 claims 1
- JJAGIHLMZAAAQP-UHFFFAOYSA-N 5-fluoro-2-[(3-methyl-2-propan-2-yloxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)OC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=CC=C2C1 JJAGIHLMZAAAQP-UHFFFAOYSA-N 0.000 claims 1
- MCAZANBPBDWLKT-UHFFFAOYSA-N 5-fluoro-2-[[3-methyl-2-(2-methylprop-1-enyl)benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound CC(C)=CC1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=CC=C2C1 MCAZANBPBDWLKT-UHFFFAOYSA-N 0.000 claims 1
- RCKNFKFXUYXQGD-HWKANZROSA-N 5-fluoro-2-[[3-methyl-2-[(e)-prop-1-enyl]benzoyl]amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C\C=C\C1=C(C)C=CC=C1C(=O)NC1(C(O)=O)CC2=CC(F)=CC=C2C1 RCKNFKFXUYXQGD-HWKANZROSA-N 0.000 claims 1
- ZEZCZUQIVHQJHW-UHFFFAOYSA-N 5-methoxy-2-(5,6,7,8-tetrahydronaphthalene-1-carbonylamino)-1,3-dihydroindene-2-carboxylic acid Chemical compound C1CCCC2=C1C=CC=C2C(=O)NC1(C(O)=O)CC2=CC=C(OC)C=C2C1 ZEZCZUQIVHQJHW-UHFFFAOYSA-N 0.000 claims 1
- ZFNNJCNJQGPLHU-UHFFFAOYSA-N 5-methoxy-2-[(3-methyl-2-propan-2-yloxybenzoyl)amino]-1,3-dihydroindene-2-carboxylic acid Chemical compound C1C2=CC(OC)=CC=C2CC1(C(O)=O)NC(=O)C1=CC=CC(C)=C1OC(C)C ZFNNJCNJQGPLHU-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 108010061298 CXCR5 Receptors Proteins 0.000 claims 1
- 102000012001 CXCR5 Receptors Human genes 0.000 claims 1
- NAWVGYMUSFGIFN-UHFFFAOYSA-N ClC=1C=C2CC(CC2=CC1)(C(=O)O)NC(C1=C(C(=CC=C1)C)C=C(C)C)=O.ClC=1C=C2CC(CC2=CC1)(C(=O)O)NC(C1=C(C(=CC=C1)C)CC(C)C)=O Chemical compound ClC=1C=C2CC(CC2=CC1)(C(=O)O)NC(C1=C(C(=CC=C1)C)C=C(C)C)=O.ClC=1C=C2CC(CC2=CC1)(C(=O)O)NC(C1=C(C(=CC=C1)C)CC(C)C)=O NAWVGYMUSFGIFN-UHFFFAOYSA-N 0.000 claims 1
- GGQUHFALWYXUAB-UHFFFAOYSA-N FC1=C2CC(CC2=C(C=C1)F)(C(=O)O)NC(C1=C(C(=CC=C1)C)C=C(C)C)=O.FC1=C2CC(CC2=CC=C1F)(C(=O)O)NC(C1=C(C(=CC=C1)C)CC(C)C)=O Chemical compound FC1=C2CC(CC2=C(C=C1)F)(C(=O)O)NC(C1=C(C(=CC=C1)C)C=C(C)C)=O.FC1=C2CC(CC2=CC=C1F)(C(=O)O)NC(C1=C(C(=CC=C1)C)CC(C)C)=O GGQUHFALWYXUAB-UHFFFAOYSA-N 0.000 claims 1
- CLIGIUYRXLDCKQ-UHFFFAOYSA-N FC=1C=C2CC(CC2=CC1)(C(=O)O)NC(=O)C1=CC=CC=2CCCCC12.C1(=CC=CC=2CCCCC12)C(=O)NC1(CC2=CC=C(C=C2C1)C(F)(F)F)C(=O)O Chemical compound FC=1C=C2CC(CC2=CC1)(C(=O)O)NC(=O)C1=CC=CC=2CCCCC12.C1(=CC=CC=2CCCCC12)C(=O)NC1(CC2=CC=C(C=C2C1)C(F)(F)F)C(=O)O CLIGIUYRXLDCKQ-UHFFFAOYSA-N 0.000 claims 1
- 230000001668 ameliorated effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- DNVCYIOZXBPRKS-GFCCVEGCSA-N C[C@@]1(Cc2cc(N)ccc2C1)C(OC)=O Chemical compound C[C@@]1(Cc2cc(N)ccc2C1)C(OC)=O DNVCYIOZXBPRKS-GFCCVEGCSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94216907P | 2007-06-05 | 2007-06-05 | |
| US60/942,169 | 2007-06-05 | ||
| PCT/US2008/065711 WO2008151211A1 (en) | 2007-06-05 | 2008-06-04 | Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010530847A JP2010530847A (ja) | 2010-09-16 |
| JP2010530847A5 true JP2010530847A5 (cg-RX-API-DMAC7.html) | 2011-06-23 |
| JP5674463B2 JP5674463B2 (ja) | 2015-02-25 |
Family
ID=39705347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511290A Expired - Fee Related JP5674463B2 (ja) | 2007-06-05 | 2008-06-04 | 置換されたベンゾイルアミノ−インダン−２−カルボン酸及び関連化合物 |
Country Status (28)
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY154462A (en) | 2007-06-05 | 2015-06-30 | Sanofi Aventis | Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| SG10201609105YA (en) * | 2008-05-05 | 2016-12-29 | Sanofi Aventis | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| AR074760A1 (es) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| EP2316818A1 (en) * | 2009-11-03 | 2011-05-04 | Active Biotech AB | Method for the preparation of 2-amino-6-ethylbenzoic acid |
| CN101735041B (zh) * | 2009-12-17 | 2013-06-12 | 太仓市运通化工厂 | 一种邻羧基苯甲醛的制备方法 |
| EP2582674B1 (en) * | 2010-06-16 | 2014-10-01 | Cymabay Therapeutics, Inc. | Gpr120 receptor agonists and uses thereof |
| US8299117B2 (en) | 2010-06-16 | 2012-10-30 | Metabolex Inc. | GPR120 receptor agonists and uses thereof |
| WO2013060865A1 (en) | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| CN107478843A (zh) * | 2012-06-27 | 2017-12-15 | 吉安特科技公司 | 用于炎性疾病的抗‑cxcl9、抗‑cxcl10、抗‑cxcl11、抗‑cxcl13、抗‑cxcr3和抗‑cxcr5试剂 |
| EP3319968A1 (en) | 2015-07-06 | 2018-05-16 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
| US20180194769A1 (en) | 2015-07-06 | 2018-07-12 | Rodin Therapeutics, Inc. | Hetero-halo inhibitors of histone deacetylase |
| GB201615191D0 (en) * | 2016-09-07 | 2016-10-19 | Takeda Pharmaceuticals Co | Novel compounds |
| JP6756925B2 (ja) | 2017-01-11 | 2020-09-16 | ロダン・セラピューティクス，インコーポレーテッド | ヒストンデアセチラーゼの二環式阻害剤 |
| GB201704476D0 (en) | 2017-03-21 | 2017-05-03 | Antabio Sas | Chemical compounds |
| SMT202200232T1 (it) | 2017-08-07 | 2022-07-21 | Alkermes Inc | Inibitori biciclici di istone deacetilasi |
| PE20251292A1 (es) | 2018-03-08 | 2025-05-14 | Incyte Corp | Compuestos diolicos de aminopirazina como inhibidores de pi3k-gamma |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| WO2020064175A1 (en) | 2018-09-25 | 2020-04-02 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
| EP3628666A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
| CN113166084B (zh) | 2018-09-25 | 2024-06-04 | 安塔比奥公司 | 用于治疗细菌感染的茚满衍生物 |
| EP3628672A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
| MA53188A1 (fr) * | 2018-10-11 | 2021-12-31 | Basf As | Composés aromatiques et leurs utilisations pharmaceutiques |
| CN110938015B (zh) * | 2019-12-06 | 2022-10-25 | 重庆工商大学 | 一种叠氮基取代的水杨酸衍生物的制备方法 |
| WO2021191240A1 (en) | 2020-03-24 | 2021-09-30 | Antabio Sas | Combination therapy |
| WO2021202553A1 (en) * | 2020-03-31 | 2021-10-07 | Yale University | Cxcr5 antagonists and methods of treating diseases or disorders using same |
| WO2021224220A1 (en) | 2020-05-06 | 2021-11-11 | Bayer Aktiengesellschaft | Pyridine (thio)amides as fungicidal compounds |
| CN116157397B (zh) | 2020-06-04 | 2025-07-15 | 拜耳公司 | 作为新杀真菌剂的杂环基吡啶 |
| WO2023042314A1 (ja) * | 2021-09-15 | 2023-03-23 | 和幸 吉崎 | 免疫異常性炎症性疾患を治療または予防するための組成物 |
| JP2024543953A (ja) | 2021-11-30 | 2024-11-26 | バイエル、アクチエンゲゼルシャフト | 抗真菌化合物としてのビス（ヘテロ）アリールチオエーテルオキサジアジン |
| CN116217415B (zh) * | 2023-02-13 | 2024-06-18 | 武汉大学 | 一种合成手性3-氨基-1-苯基丙醇和手性3-(甲氨基)-1-苯基丙醇的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2701480B1 (fr) * | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| PL335027A1 (en) * | 1997-02-03 | 2000-03-27 | Pfizer Prod Inc | Derivatives of arylsulphonylamino hydroxamic acid |
| US5932765A (en) * | 1997-05-23 | 1999-08-03 | Merck Patent Gesellschaft Mit | Nitromethyl ketones, process for preparing them and compositions containing them |
| JP2002501537A (ja) * | 1997-05-29 | 2002-01-15 | メルク エンド カンパニー インコーポレーテッド | 細胞接着阻害薬としてのスルホンアミド類 |
| CA2298617A1 (en) * | 1997-07-31 | 1999-02-11 | Yetunde Olabisi Taiwo | Acyclic metalloprotease inhibitors |
| US6929928B2 (en) * | 2003-06-12 | 2005-08-16 | E. I. Du Pont De Nemours And Company | Genes encoding carotenoid compounds |
| US20090018145A1 (en) * | 2004-10-19 | 2009-01-15 | Compass Pharmaceuticals Llc | Compositions and their use as anti-tumor agents |
| EP1676834A1 (en) * | 2004-12-30 | 2006-07-05 | Sanofi-Aventis Deutschland GmbH | Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| JPWO2006088246A1 (ja) * | 2005-02-18 | 2008-07-10 | 武田薬品工業株式会社 | Ｇｐｒ３４受容体機能調節剤 |
| MX2008015768A (es) * | 2006-06-28 | 2009-01-07 | Sanofi Aventis | Nuevos inhibidores de cxcr2. |
| WO2008000407A1 (en) * | 2006-06-28 | 2008-01-03 | Sanofi-Aventis | Inhibitors of cxcr2 |
| WO2008036967A2 (en) * | 2006-09-22 | 2008-03-27 | Reddy Us Therapeutics, Inc. | Novel heterocyclic compounds as lasy activators |
| MY154462A (en) | 2007-06-05 | 2015-06-30 | Sanofi Aventis | Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| SG10201609105YA (en) * | 2008-05-05 | 2016-12-29 | Sanofi Aventis | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
-
2008
- 2008-06-04 MY MYPI20094880A patent/MY154462A/en unknown
- 2008-06-04 NZ NZ581610A patent/NZ581610A/en not_active IP Right Cessation
- 2008-06-04 CA CA2690001A patent/CA2690001C/en not_active Expired - Fee Related
- 2008-06-04 EP EP08770082A patent/EP2155711A1/en not_active Withdrawn
- 2008-06-04 RU RU2009149465/04A patent/RU2477279C2/ru not_active IP Right Cessation
- 2008-06-04 WO PCT/US2008/065711 patent/WO2008151211A1/en not_active Ceased
- 2008-06-04 KR KR1020107000169A patent/KR101583487B1/ko not_active Expired - Fee Related
- 2008-06-04 JP JP2010511290A patent/JP5674463B2/ja not_active Expired - Fee Related
- 2008-06-04 CN CN200880019016.XA patent/CN101679346B/zh not_active Expired - Fee Related
- 2008-06-04 TW TW097120661A patent/TWI446905B/zh not_active IP Right Cessation
- 2008-06-04 MX MX2009011615A patent/MX2009011615A/es active IP Right Grant
- 2008-06-04 AU AU2008259804A patent/AU2008259804B2/en not_active Ceased
- 2008-06-04 CL CL2008001632A patent/CL2008001632A1/es unknown
- 2008-06-05 UY UY31122A patent/UY31122A1/es not_active Application Discontinuation
- 2008-06-05 AR ARP080102399A patent/AR066880A1/es unknown
- 2008-06-05 PA PA20088783001A patent/PA8783001A1/es unknown
- 2008-06-05 PE PE2008000961A patent/PE20090361A1/es not_active Application Discontinuation
-
2009
- 2009-10-22 ZA ZA200907414A patent/ZA200907414B/xx unknown
- 2009-11-03 CO CO09123805A patent/CO6251356A2/es not_active Application Discontinuation
- 2009-11-06 NI NI200900201A patent/NI200900201A/es unknown
- 2009-11-26 SV SV2009003422A patent/SV2009003422A/es unknown
- 2009-11-26 CR CR11130A patent/CR11130A/es not_active Application Discontinuation
- 2009-11-30 US US12/627,546 patent/US8569535B2/en active Active
- 2009-12-02 GT GT200900311A patent/GT200900311A/es unknown
- 2009-12-02 IL IL202473A patent/IL202473A/en active IP Right Grant
- 2009-12-03 EC EC2009009782A patent/ECSP099782A/es unknown
- 2009-12-03 DO DO2009000275A patent/DOP2009000275A/es unknown
-
2010
- 2010-01-04 MA MA32478A patent/MA31504B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530847A5 (cg-RX-API-DMAC7.html) | ||
| RU2009149465A (ru) | Замещенные бензоиламиноиндан-2-карбоновые кислоты и родственные соединения | |
| ES2358426T3 (es) | Compuestos para la inflamación y usos inmunorrelacionados. | |
| TWI398432B (zh) | Ｔａｓｋ-１及ｔａｓｋ-３離子通道之抑制劑 | |
| CA2780433C (en) | Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | |
| SI2303270T1 (en) | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceutical products | |
| JPWO2005012221A1 (ja) | ジフェニルエーテル化合物、その製造方法および用途 | |
| ES2752039T3 (es) | Agente terapéutico para la dislipidemia | |
| ES2750309T3 (es) | Nuevos derivados de arilamida que tienen propiedades antiandrogénicas | |
| US20070088027A1 (en) | Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient | |
| JP2006522748A5 (cg-RX-API-DMAC7.html) | ||
| JP2014502979A5 (cg-RX-API-DMAC7.html) | ||
| JP2010501584A5 (cg-RX-API-DMAC7.html) | ||
| WO2003057225A2 (en) | Phosphate transport inhibitors | |
| JP2011510080A5 (cg-RX-API-DMAC7.html) | ||
| JP2012521428A5 (cg-RX-API-DMAC7.html) | ||
| JP2013521286A5 (cg-RX-API-DMAC7.html) | ||
| JP2013508279A5 (cg-RX-API-DMAC7.html) | ||
| JP2012521429A5 (cg-RX-API-DMAC7.html) | ||
| JP2011504903A5 (cg-RX-API-DMAC7.html) | ||
| CN105980372B (zh) | 官能化的苯并吡喃化合物及其用途 | |
| JP2010522710A5 (cg-RX-API-DMAC7.html) | ||
| JP2008513508A (ja) | 炎症及び免疫に関連する用途に用いる化合物 | |
| JP2011529037A5 (cg-RX-API-DMAC7.html) | ||
| JP2008539268A5 (cg-RX-API-DMAC7.html) |